NeuroSense's PrimeC composition receives Brazilian patent
7 April 2026 - NeuroSense Therapeutics Ltd (NASDAQ:NRSN), a late-clinical stage biotechnology company developing treatments for severe neurodegenerative diseases, announced on Monday that the Brazilia...
M2 Pharma
via M2 Pharma
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Greensprings graduates demonstrate diverse pathways to success
Next
It Ends With Us star responds to judge's ruling in sexual harassment lawsuit
Related Articles
ScienceNew CEO for Environmental Protection Authority
Unknown-just now-1 sources
Amid Iran war, 53 of Israel's future scientists showcase projects in Jerusalem contest
Judy Siegel-Itzkovich-just now-1 sources
Primal Queen vs Her Bodhi reviews (2026): Why Her Bodhi is a science-backed alternative?
David Rabinowicz-18m ago-1 sources